摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-2,4,9,11-tetraoxadodec-6-ene | 62585-60-8

中文名称
——
中文别名
——
英文名称
(Z)-2,4,9,11-tetraoxadodec-6-ene
英文别名
(Z)-1,4-bis(methoxymethoxy)but-2-ene
(Z)-2,4,9,11-tetraoxadodec-6-ene化学式
CAS
62585-60-8
化学式
C8H16O4
mdl
——
分子量
176.213
InChiKey
CIRVPBPYQAXQFD-ARJAWSKDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    12
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    36.9
  • 氢给体数:
    0
  • 氢受体数:
    4

SDS

SDS:f5c95f2f5888e4605f71e28c5b66d912
查看

反应信息

点击查看最新优质反应信息

文献信息

  • S<sub>N</sub>2″-Selective and Enantioselective Substitution with Unsaturated Organoboron Compounds and Catalyzed by a Sulfonate-Containing NHC-Cu Complex
    作者:Yuebiao Zhou、Ying Shi、Sebastian Torker、Amir H. Hoveyda
    DOI:10.1021/jacs.8b10885
    日期:2018.12.5
    53-89% yield, 69-96% SN2″ selectivity, 98:2 to >98:2 E: Z ratio, and 94:6-98:2 er. Insight regarding several of the unique mechanistic attributes of the catalytic process was obtained on the basis of kinetic isotope effect measurements and DFT studies. These investigations indicate that cationic π-allyl-Cu complexes are likely intermediates, clarifying the role of the s-cis and s-trans conformers of
    公开了第一个广泛适用的 SN2" 选择性和对映选择性催化取代策略。转化由 5.0 mol% 的含磺酸盐的 NHC-Cu 复合物(NHC = N-杂环卡宾)促进,并在市售的烯基-B(pin)(pin = pinacolato)或易于获得的甲硅烷基保护的炔丙基-B(pin)。发现无环、或芳基-、杂芳基-和烷基取代的五-2,4-二烯基磷酸酯,以及仅带有1,2-二取代烯烃或1,2-二取代和三取代烯烃的那些是合适的起始材料。环状磷酸二烯酯也可用作底物。以 51-82% 的收率获得了除 1,3-二烯基外还含有易于官能化的炔丙基部分(来自与丙二烯基-B(pin) 的反应)的产物,84-97% SN2" 选择性,89:11-97:3 E: Z 比和 86:14-98:2 对映体比 (er)。与甲硅烷基保护的炔丙基-B(pin) 化合物反应导致形成相应的甲硅烷基-烯丙基产物,产率 53-89%,SN2" 选择性
  • Intermolecular Enantioselective Heck–Matsuda Arylations of Acyclic Olefins: Application to the Synthesis of β-Aryl-γ-lactones and β-Aryl Aldehydes
    作者:Caio C. Oliveira、Ricardo A. Angnes、Carlos Roque D. Correia
    DOI:10.1021/jo400378g
    日期:2013.5.3
    intermolecular Heck–Matsuda arylation of acyclic allylic alcohols. Aryldiazonium tetrafluoroborates were applied as arylating agents in the presence of Pd(TFA)2 and a chiral, commercially available, bisoxazoline ligand. The methodology is straightforward, robust, scalable up to a few grams, and of broad scope allowing the synthesis of a range of β-aryl-carbonyl compounds in good to high enantioselectivities
    我们在本文中描述了一种用于无环烯丙基醇的对映选择性分子内Heck-Matsuda芳基化的合成方法。在Pd(TFA)2和手性的市售双恶唑啉配体的存在下,将芳基重氮四氟硼酸盐用作芳基化剂。该方法简单,稳健,可扩展至几克,并且适用范围广,可以合成一系列良好至高对映选择性和高产率的β-芳基-羰基化合物。这种新的对映选择性的Heck-Matsuda芳基化反应可以合成β-芳基-γ-内酯和β-芳基醛,它们在合成生物活性化合物(如(R)-baclofen,(R)-咯利普兰,(S)-姜黄烯,(S)-脱氢姜黄烯和(S)-肿瘤素。
  • Highly selective one-pot conversion of THP and MOM ethers to acetates by indium triiodide-catalysed deprotection and subsequent transesterification by ethyl acetate
    作者:Brindaban C. Ranu、Alakananda Hajra
    DOI:10.1039/b104055n
    日期:——
    A simple and efficient method is developed for the chemoselective one-pot conversion of tetrahydropyranyl (THP) and methoxymethyl (MOM) ethers of primary alcohols to the corresponding acetates by indium triiodide-catalysed deprotection and subsequent acetylation by ethyl acetate through a transesterification process.
    我们开发了一种简单而高效的方法,通过铟三碘催化去保护和随后的醋酸乙酯转酯化过程,将初级醇的四氢吡喃基(THP)和甲氧基甲基(MOM)醚选择性地一锅转化为相应的醋酸酯。
  • ACYCLIC AMINE INHIBITORS OF 5-METHYTIOADENOSINE PHOSPHORYLASE AND NUCLEOSIDASE
    申请人:Clinch Keith
    公开号:US20110046167A1
    公开(公告)日:2011-02-24
    The present invention relates to compounds of the general formula (I) which are inhibitors of 5′-methylthioadenosine phosphorylase or 5′-methylthioadenosine nucleosidase. The invention also relates to the use of these compounds in the treatment of diseases or conditions in which it is desirable to inhibit 5′-methylthioadenosine phosphorylase or 5′-methylthioadenosine nucleosidase including cancer, and to pharmaceutical compositions containing the compounds.
    本发明涉及一般公式(I)的化合物,它们是5'-甲基硫腺苷磷酸化酶或5'-甲基硫腺苷核苷酸酶的抑制剂。本发明还涉及使用这些化合物治疗希望抑制5'-甲基硫腺苷磷酸化酶或5'-甲基硫腺苷核苷酶的疾病或病况,包括癌症,并且涉及含有这些化合物的药物组合物。
  • Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
    申请人:Clinch Keith
    公开号:US20110130412A1
    公开(公告)日:2011-06-02
    The invention relates to compounds of the general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNPs) and/or nucleoside hydrolases (NHs). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
    本发明涉及一般式(I)的化合物,其为嘌呤核苷酸磷酸酯酶(PNP)和/或核苷酸水解酶(NH)的抑制剂。本发明还涉及这些化合物在治疗疾病和感染,包括癌症,细菌感染,原虫感染和T细胞介导的疾病中的使用,以及含有这些化合物的制药组合物。
查看更多